Chemoradiotherapy Improves Survival for Elderly With NSCLC - Monthly Prescribing Reference

(HealthDay News) – For elderly patients with locally advanced non-small-cell lung cancer (NSCLC), treatment with radiotherapy plus carboplatin improves overall survival versus radiotherapy alone, according to a study published May 22 in The Lancet Oncology.

Chemotherapy and radiation given together could help elderly patients with lung cancer live longer - medicalxpress.com

However, new research published Online First in The Lancet Oncology shows that giving a daily low-dose of the chemotherapy drug carboplatin at the same time as radiotherapy significantly prolongs survival in elderly patients compared with ...

Rexahn Pharmaceuticals Submits Archexin Phase II Protocol for Ovarian Cancer to FDA - Yahoo Finance

The Phase II study will assess the safety and efficacy of Archexin when used in combination with both carboplatin and paclitaxel as a second-line therapy in subjects who are platinum-sensitive following their first relapse. The study will be ...

Endometrial Cancer: Drop the Doxorubicin - Medscape News

However, important data from this current trial reveal that the combination of carboplatin and paclitaxel was equivalent or not inferior in efficacy and was substantially less toxic [than the 3-drug combination]. This is not surprising ...

Phase 3 MISSION trial of Nexavar (sorafenib) in Patients with Non-Small Cell Lung Cancer Did Not Meet Primary Endpoint of Improving Overall Survival - Yahoo Finance

Important Safety Considerations For Nexavar (sorafenib) Nexavar in combination with carboplatin and paclitaxel is contraindicated in patients with squamous cell lung cancer. Nexavar may cause fetal harm when administered to a pregnant woman.

Negative Data No Negation of Drug's Utility - Medscape News

They compared a group of 318 patients who received carboplatin and paclitaxel plus bevacizumab against the remainder of the population of 4000 who [received carboplatin and paclitaxel alone] and concluded that bevacizumab added minimal ...

Abdominal fluid build up, now on Gemzar - American Cancer Society

She had paracentesis at the time to drain the fluid, but the chemo she was started on at the time(Taxol/Carboplatin) took care of the fluid. She had an excellent initial response, and after undergoing chemo, surgery, chemo again and then Intra-abdominal ...

Rexahn Pharmaceuticals: Update On Cancer Drugs - Seekingalpha.com

The Phase II trial will assess the safety and efficacy of Archexin when used in combination with both carboplatin and paclitaxel. The study will be conducted at multiple centers in the United States. Ovarian cancer is the fifth most common cancer among ...

Eisai Oncology to Present New Research on Product Portfolio and Pipeline at ASCO Annual Meeting - PR Newswire

Carboplatin and Pegylated Liposomal Doxorubicin (PLD) in Patients with Farletuzumab Platinum-Sensitive Epithelial Ovarian Cancer (EOC) MORAb-003 Abstract No: 5062 Poster Session Phase I and Pharmacokinetic Study of Farletuzumab in Farletuzumab Solid ...